Hinge Health (HNGE) Cash & Equivalents (2024 - 2026)

Hinge Health has disclosed Cash & Equivalents across 3 years of filings, most recently posting $286.2 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 20.68% year-over-year to $286.2 million; the TTM figure through Jun 2026 stood at $286.2 million (up 20.68% YoY), while the FY2025 annual figure was $208.0 million, down 30.85% from the prior year.
• Cash & Equivalents came in at $286.2 million for Q2 2026 at Hinge Health, up from $186.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $300.8 million in Q4 2024 to a low of $186.7 million in Q1 2026.
• Average Cash & Equivalents over 3 years is $252.5 million, with a median of $261.3 million recorded in 2025.
• The largest YoY upside for Cash & Equivalents was 20.68% in 2026 against a maximum downside of 35.29% in 2026.
• Over 3 years, Cash & Equivalents stood at $300.8 million in 2024, then slumped by 30.85% to $208.0 million in 2025, then soared by 37.61% to $286.2 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $286.2 million in Q2 2026, $186.7 million in Q1 2026, and $208.0 million in Q4 2025.